Harp Diagnostics

Remote & rapid monitoring platform for superior disease management of IBD and other GI conditions

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in December 2022, Harp Diagnostics operates with 1–10 employees. The company secured seed funding in February 2023 from The Trendlines Group. A significant milestone for the company was winning the IBD Innovate Conference Shark Tank competition in April 2025.

Business overview

Harp Diagnostics is developing an automated, user-friendly, and rapid stool testing platform for home monitoring of gastrointestinal conditions, specifically Inflammatory Bowel Diseases (IBD) such as Crohn’s and Colitis. Its core technology is a patented portable device designed for seamless sample collection and accurate results, eliminating human error. The platform serves patients and healthcare providers, enabling real-time data-driven decisions for treatment adjustments and improving continuity of care. The company operates within the Health Tech & Life Sciences sector, focusing on medical devices, remote monitoring, and digital healthcare.

Strategic signal

In April 2025, Harp Diagnostics won the IBD Innovate Conference Shark Tank competition, a significant validation of its technology and approach to managing Inflammatory Bowel Diseases. This achievement, alongside securing a grant from The US Crohn's & Colitis Foundation in the same month, signals strong industry recognition and potential for market adoption, positioning the company for accelerated development and strategic partnerships in the health tech and life sciences sector.

Company Intelligence Q&A

What is Harp Diagnostics' primary focus?
Harp Diagnostics is focused on developing an automated, user-friendly, and rapid stool testing platform for remote monitoring of gastrointestinal conditions, particularly Inflammatory Bowel Diseases (IBD).
When was Harp Diagnostics founded?
Harp Diagnostics was founded in December 2022.
Did Harp Diagnostics receive any seed funding?
Yes, Harp Diagnostics received seed funding in February 2023 from The Trendlines Group.
Has Harp Diagnostics received any notable awards or recognition?
In April 2025, Harp Diagnostics won the IBD Innovate Conference Shark Tank competition. The company was also a finalist for the 2025 ASPER HUJI Innovate prize.
What is the Harp 360 product?
HARP 360 is the company's product, an end-to-end solution for at-home or point-of-care gastrointestinal monitoring, featuring seamless sample collection and rapid, accurate results shared via a cloud-connected system.